ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Ascentage Pharma Announces First Patient Dosed in the Global Phase Ib/II Clinical Study of Bcl-2 Inhibitor APG-2575 in the United States
March 23, 2020Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the global Phase Ib/II clinical study of APG-
Pharma Sources Insight January 2025
